Resatorvid‐based Pharmacological Antagonism of Cutaneous TLR4 Blocks UV‐induced NF‐κB and AP‐1 Signaling in Keratinocytes and Mouse Skin

Cutaneous exposure to solar ultraviolet (UV) radiation is a major causative factor in skin carcinogenesis, and improved molecular strategies for efficacious chemoprevention of nonmelanoma skin cancer (NMSC) are urgently needed. Toll‐like receptor 4 (TLR4) signaling has been shown to drive skin inflammation, photoimmunosuppression, and chemical carcinogenesis. Here we have examined the feasibility of genetic and pharmacological antagonism targeting cutaneous TLR4 for the suppression of UV‐induced NF‐κB and AP‐1 signaling in keratinocytes and mouse skin. Using immunohistochemical and proteomic microarray analysis of human skin, we demonstrate for the first time that a significant increase in expression of TLR4 occurs in keratinocytes during the progression from normal skin to actinic keratosis, also detectible during further progression to squamous cell carcinoma. Next, we demonstrate that siRNA‐based genetic TLR4 inhibition blocks UV‐induced stress signaling in cultured keratinocytes. Importantly, we observed that resatorvid (TAK‐242), a molecularly targeted clinical TLR4 antagonist, blocks UV‐induced NF‐κB and MAP kinase/AP‐1 activity and cytokine expression (Il‐6, Il‐8, and Il‐10) in cultured keratinocytes and in topically treated murine skin. Taken together, our data reveal that pharmacological TLR4 antagonism can suppress UV‐induced cutaneous signaling, and future experiments will explore the potential of TLR4‐directed strategies for prevention of NMSC.

[1]  Dong Hun Lee,et al.  Serum amyloid A1 secreted from UV‐irradiated keratinocytes induces matrix metalloproteinase‐1 in fibroblasts through toll‐like receptor 4 , 2016, Experimental dermatology.

[2]  Jieling Zhao,et al.  Unique Toll-Like Receptor 4 Activation by NAMPT/PBEF Induces NFκB Signaling and Inflammatory Lung Injury , 2015, Scientific Reports.

[3]  E. Petricoin,et al.  Functional Protein Pathway Activation Mapping of the Progression of Normal Skin to Squamous Cell Carcinoma , 2012, Cancer Prevention Research.

[4]  Xiaoyong Wang,et al.  Increased MAPK and NF-κB expression of Langerhans cells is dependent on TLR2 and TLR4, and increased IRF-3 expression is partially dependent on TLR4 following UV exposure. , 2011, Molecular medicine reports.

[5]  Yunhua Deng,et al.  Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors , 2013, BMC Cancer.

[6]  Donna D. Zhang,et al.  Systemic administration of the apocarotenoid bixin protects skin against solar UV-induced damage through activation of NRF2. , 2015, Free radical biology & medicine.

[7]  N. Yusuf,et al.  Toll-Like Receptors and Skin Cancer , 2014, Front. Immunol..

[8]  C. Mai,et al.  Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers , 2013, OncoTargets and therapy.

[9]  G. T. Bowden,et al.  Inhibitory effects of perillyl alcohol on UVB-induced murine skin cancer and AP-1 transactivation. , 1998, Cancer research.

[10]  M. Bianchi,et al.  TLR4‐mediated skin carcinogenesis is dependent on immune and radioresistant cells , 2010, The EMBO journal.

[11]  A. Bode,et al.  Signal transduction pathways: targets for chemoprevention of skin cancer. , 2000, The Lancet. Oncology.

[12]  D. Alberts,et al.  p38 MAP kinase plays a functional role in UVB‐Induced mouse skin carcinogenesis , 2011, Molecular carcinogenesis.

[13]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[14]  S. Cooper,et al.  Ultraviolet B regulation of transcription factor families: roles of nuclear factor-kappa B (NF-kappaB) and activator protein-1 (AP-1) in UVB-induced skin carcinogenesis. , 2007, Current cancer drug targets.

[15]  G. Bowden,et al.  Phase II enzyme inducer, sulforaphane, inhibits UVB‐induced AP‐1 activation in human keratinocytes by a novel mechanism , 2004, Molecular carcinogenesis.

[16]  Jon Cohen,et al.  A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis* , 2010, Critical care medicine.

[17]  K. Triantafilou,et al.  Heat-shock protein 70 and heat-shock protein 90 associate with Toll-like receptor 4 in response to bacterial lipopolysaccharide. , 2004, Biochemical Society transactions.

[18]  D. Alberts,et al.  Quercetin Potentiates UVB-Induced c-Fos Expression: Implications for Its Use as a Chemopreventive Agent , 2010, Cancer Prevention Research.

[19]  A. Bode,et al.  Myricetin suppresses UVB-induced skin cancer by targeting Fyn. , 2008, Cancer research.

[20]  I. A. Gomez de Segura,et al.  The Effects of the Toll-Like Receptor 4 Antagonist, Ibudilast, on Sevoflurane’s Minimum Alveolar Concentration and the Delayed Remifentanil-Induced Increase in the Minimum Alveolar Concentration in Rats , 2016, Anesthesia and analgesia.

[21]  G. Wondrak.  Sunscreen-Based Skin Protection Against Solar Insult: Molecular Mechanisms and Opportunities , 2019, Fundamentals of Cancer Prevention.

[22]  T. Kaisho,et al.  Analysis of binding site for the novel small‐molecule TLR4 signal transduction inhibitor TAK‐242 and its therapeutic effect on mouse sepsis model , 2009, British journal of pharmacology.

[23]  N. Yusuf,et al.  Regulation of ultraviolet radiation induced cutaneous photoimmunosuppression by toll-like receptor-4. , 2011, Archives of biochemistry and biophysics.

[24]  Haichao Wang,et al.  Carbenoxolone Blocks Endotoxin-Induced Protein Kinase R (PKR) Activation and High Mobility Group Box 1 (HMGB1) Release , 2013, Molecular Medicine.

[25]  E. Petricoin,et al.  Inhibition of Akt Enhances the Chemopreventive Effects of Topical Rapamycin in Mouse Skin , 2016, Cancer Prevention Research.

[26]  S. Dickinson,et al.  Inhibition of activator protein-1 by sulforaphane involves interaction with cysteine in the cFos DNA-binding domain: implications for chemoprevention of UVB-induced skin cancer. , 2009, Cancer research.

[27]  N. Yusuf,et al.  Baicalin Protects Keratinocytes from Toll‐like Receptor‐4 Mediated DNA Damage and Inflammation Following Ultraviolet Irradiation , 2015, Photochemistry and photobiology.

[28]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[29]  D. Alberts,et al.  Genetic ablation of caspase-7 promotes solar-simulated light-induced mouse skin carcinogenesis: the involvement of keratin-17. , 2015, Carcinogenesis.

[30]  Grazia Gallo,et al.  Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound , 2007, Journal of leukocyte biology.

[31]  S. Bhattacharjee,et al.  Prolonged inflammatory microenvironment is crucial for pro-neoplastic growth and genome instability: a detailed review , 2017, Inflammation Research.

[32]  S. Ran.  The Role of TLR4 in Chemotherapy-Driven Metastasis. , 2015, Cancer research.

[33]  Cooper Sj,et al.  Ultraviolet B Regulation of Transcription Factor Families: Roles of Nuclear Factor-kappa B (NF-κB) and Activator Protein-1 (AP-1) in UVB-Induced Skin Carcinogenesis , 2007 .

[34]  G. T. Bowden,et al.  Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling , 2004, Nature Reviews Cancer.

[35]  D. Schadendorf,et al.  Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma , 2014, Nature.

[36]  K.,et al.  Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011. , 2015, American journal of preventive medicine.

[37]  D. Alberts,et al.  A novel chemopreventive mechanism for a traditional medicine: East Indian sandalwood oil induces autophagy and cell death in proliferating keratinocytes. , 2013, Archives of biochemistry and biophysics.

[38]  S. Awasthi,et al.  Toll-Like Receptor-4 Modulation for Cancer Immunotherapy , 2014, Front. Immunol..

[39]  Erin M. Harberts,et al.  Ultraviolet Radiation Signaling through TLR4/MyD88 Constrains DNA Repair and Plays a Role in Cutaneous Immunosuppression , 2015, The Journal of Immunology.